Eisai Co., Ltd. (ESALY) Stock Analysis
DELISTED
What happened to Eisai Co., Ltd. (ESALY) stock?
Eisai Co., Ltd. (ESALY) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
P/E 61.00 means the share price is 61.00 times one year of earnings per share. Market cap $17.6B is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Eisai Co., Ltd. (ESALY). Eisai Co., Ltd. is a Japan-based pharmaceutical company focused on neurology, oncology, and global generic medicines. The company aims to address unmet medical needs and improve the lives of patients and their families worldwide.
Last analyzed: Mar 17, 2026Eisai Co., Ltd. (ESALY) Healthcare & Pipeline Overview
Eisai Co., Ltd. ADR Information Unsponsored
Eisai Co., Ltd. (ESALY) trades in the U.S. as an American Depositary Receipt (ADR).
- ADR Level: 1
- ADR Ratio: 1:1
- Home Market Ticker: ESAL
ESALY OTC Market Information
ESALY trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy ESALY shares?
No. ESALY stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for ESALY elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before ESALY stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Eisai Co., Ltd.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.